Laboratory Corporation of America HoldingsNYSE:LH
- LAST PRICE207.4500
- TODAY'S CHANGE (%)1.3000 (0.6306%)
- Bid / Lots207.2500/ 4
- Ask / Lots207.5500/ 2
- Open / Previous Close206.3400 / 206.1500
- Day Range
- 52 Week Range
- Volume235,667
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LH |
|---|---|---|
| 09:32 ET | 2848 | 206.185 |
| 09:34 ET | 100 | 206.9 |
| 09:38 ET | 1672 | 206.59 |
| 09:39 ET | 2400 | 206.84 |
| 09:41 ET | 100 | 207.155 |
| 09:43 ET | 3137 | 207.03 |
| 09:45 ET | 625 | 206.85 |
| 09:48 ET | 100 | 206.925 |
| 09:50 ET | 200 | 206.88 |
| 09:54 ET | 105 | 206.845 |
| 09:56 ET | 100 | 206.83 |
| 09:59 ET | 200 | 206.905 |
| 10:01 ET | 5954 | 206.915 |
| 10:03 ET | 4296 | 206.77 |
| 10:06 ET | 286 | 206.82 |
| 10:08 ET | 906 | 206.99 |
| 10:10 ET | 1734 | 207.18 |
| 10:12 ET | 1683 | 207.07 |
| 10:14 ET | 409 | 207.01 |
| 10:15 ET | 605 | 207.18 |
| 10:17 ET | 3200 | 206.8 |
| 10:19 ET | 261 | 206.779 |
| 10:21 ET | 500 | 206.94 |
| 10:24 ET | 3076 | 207.0025 |
| 10:26 ET | 100 | 207.1 |
| 10:28 ET | 213 | 207.1 |
| 10:30 ET | 611 | 207.16 |
| 10:32 ET | 4089 | 207.26 |
| 10:33 ET | 700 | 207.06 |
| 10:35 ET | 300 | 207.02 |
| 10:37 ET | 2975 | 207.22 |
| 10:39 ET | 1039 | 207.3499 |
| 10:42 ET | 500 | 207.1541 |
| 10:44 ET | 808 | 207.28 |
| 10:46 ET | 521 | 207.26 |
| 10:48 ET | 2310 | 207.225 |
| 10:50 ET | 407 | 207.335 |
| 10:51 ET | 1406 | 207.325 |
| 10:53 ET | 575 | 207.35 |
| 10:55 ET | 4713 | 207.17 |
| 10:57 ET | 1555 | 207.1118 |
| 11:00 ET | 500 | 207.18 |
| 11:02 ET | 300 | 207.12 |
| 11:04 ET | 200 | 207.105 |
| 11:06 ET | 3438 | 206.96 |
| 11:09 ET | 833 | 206.85 |
| 11:13 ET | 6481 | 206.8 |
| 11:15 ET | 863 | 206.92 |
| 11:18 ET | 3927 | 207.175 |
| 11:22 ET | 2714 | 206.78 |
| 11:24 ET | 300 | 206.9 |
| 11:26 ET | 1230 | 206.835 |
| 11:27 ET | 200 | 206.835 |
| 11:29 ET | 1157 | 206.94 |
| 11:31 ET | 1502 | 207.37 |
| 11:33 ET | 2611 | 207.195 |
| 11:36 ET | 972 | 207.02 |
| 11:38 ET | 100 | 206.81 |
| 11:40 ET | 890 | 206.81 |
| 11:42 ET | 851 | 207.07 |
| 11:44 ET | 300 | 207.06 |
| 11:45 ET | 2356 | 206.94 |
| 11:47 ET | 1246 | 207.09 |
| 11:51 ET | 1700 | 207.385 |
| 11:54 ET | 300 | 207.38 |
| 11:56 ET | 4700 | 207.32 |
| 12:00 ET | 1421 | 207.38 |
| 12:02 ET | 700 | 207.32 |
| 12:03 ET | 2409 | 207.03 |
| 12:05 ET | 1702 | 207.12 |
| 12:07 ET | 533 | 207.15 |
| 12:12 ET | 1655 | 207.06 |
| 12:14 ET | 4084 | 206.93 |
| 12:16 ET | 300 | 206.97 |
| 12:18 ET | 100 | 206.88 |
| 12:20 ET | 500 | 206.875 |
| 12:21 ET | 100 | 206.865 |
| 12:23 ET | 2021 | 207.085 |
| 12:25 ET | 3351 | 207.155 |
| 12:27 ET | 300 | 207.11 |
| 12:30 ET | 200 | 207.09 |
| 12:32 ET | 810 | 207.145 |
| 12:34 ET | 600 | 207.04 |
| 12:36 ET | 7409 | 207.095 |
| 12:38 ET | 100 | 207.19 |
| 12:39 ET | 161 | 207.0348 |
| 12:41 ET | 4971 | 207.13 |
| 12:43 ET | 200 | 207.07 |
| 12:45 ET | 1852 | 207.29 |
| 12:48 ET | 2111 | 207.24 |
| 12:50 ET | 330 | 207.31 |
| 12:52 ET | 849 | 207.27 |
| 12:54 ET | 300 | 207.16 |
| 12:56 ET | 400 | 207.27 |
| 12:57 ET | 1300 | 207.505 |
| 12:59 ET | 1158 | 207.45 |
| 01:03 ET | 3085 | 207.43 |
| 01:06 ET | 100 | 207.4975 |
| 01:08 ET | 100 | 207.5025 |
| 01:10 ET | 100 | 207.545 |
| 01:12 ET | 2347 | 207.485 |
| 01:14 ET | 1294 | 207.45 |
May 8, 2024
Labcorp to Webcast Its Annual Meeting of Shareholders, from 6:59AM ET on Wednesday May 08, 2024 by Dow Jones
6:59AM ET on Wednesday May 08, 2024 by Dow Jones
May 7, 2024
Invitae Receives Court Approval for Sale to Labcorp, from 4:05PM ET on Tuesday May 07, 2024 by Dow Jones
4:05PM ET on Tuesday May 07, 2024 by Dow JonesPress Release: Invitae Receives Court Approval for Sale to Labcorp, from 4:05PM ET on Tuesday May 07, 2024 by Dow Jones
4:05PM ET on Tuesday May 07, 2024 by Dow Jones
Apr 29, 2024
DJ Laboratory Corporation of America on Pace for Largest Percent Increase Since November 2022 -- Data Talk, from 10:28AM ET on Monday Apr 29, 2024 by Dow Jones
10:28AM ET on Monday Apr 29, 2024 by Dow JonesLabcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B, from 7:00AM ET on Monday Apr 29, 2024 by Dow Jones
7:00AM ET on Monday Apr 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Laboratory Corporation of America Holdings | 17.4B | 45.4x | -13.71% |
Quest Diagnostics Inc | 15.3B | 18.6x | +7.78% |
Ventas Inc | 19.2B | -262.1x | --- |
DaVita Inc | 12.1B | 15.6x | +15.72% |
Universal Health Services Inc | 11.8B | 15.2x | +4.42% |
Healthpeak Properties Inc | 13.7B | 55.3x | -20.31% |
Company Information
Laboratory Corporation of America Holdings provides comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company serves clients in more than 100 countries.
Contact Information
- Headquarters
- 358 S MAIN STBURLINGTON, NC, United States 27215-5837
- Phone
- 336-229-1127
- Fax
- 302-636-5454
Executives
- Chairman of the Board, President, Chief Executive Officer
- Adam Schechter
- Chief Financial Officer, Executive Vice President
- Glenn Eisenberg
- President, Chief Executive Officer - Clinical Development Business Unit
- Thomas Pike
- Executive Vice President, President - Diagnostics Laboratories, Chief Operations Officer
- Mark Schroeder
- Chief Human Resource Officer, Executive Vice President
- Anita Graham
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $17.4B |
|---|---|
Revenue (TTM) | $12.3B |
Shares Outstanding | 84.3M |
Dividend Yield | 1.39% |
Annual Dividend Rate | 2.8800 USD |
Ex-Dividend Date | 05-24-24 |
Pay Date | 06-12-24 |
Beta | 1.06 |
EPS | $4.57 |
Book Value | $93.86 |
P/E Ratio | 45.4x |
Price/Sales (TTM) | 1.4 |
Price/Cash Flow (TTM) | 18.0x |
Operating Margin | 5.83% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
